These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 25443643)

  • 1. Sidestream dark field videomicroscopy for in vivo evaluation of vascularization and perfusion of mammary tumours in HER2/neu transgenic mice.
    Damiani E; Pierpaoli E; Orlando F; Donati A; Provinciali M
    Clin Exp Pharmacol Physiol; 2015 Feb; 42(2):225-9. PubMed ID: 25443643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiangiogenic and antitumor activities of berberine derivative NAX014 compound in a transgenic murine model of HER2/neu-positive mammary carcinoma.
    Pierpaoli E; Damiani E; Orlando F; Lucarini G; Bartozzi B; Lombardi P; Salvatore C; Geroni C; Donati A; Provinciali M
    Carcinogenesis; 2015 Oct; 36(10):1169-79. PubMed ID: 26168818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
    Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
    Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the silybin-phosphatidylcholine complex (IdB 1016) on the development of mammary tumors in HER-2/neu transgenic mice.
    Provinciali M; Papalini F; Orlando F; Pierpaoli S; Donnini A; Morazzoni P; Riva A; Smorlesi A
    Cancer Res; 2007 Mar; 67(5):2022-9. PubMed ID: 17332330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice.
    Howe LR; Chang SH; Tolle KC; Dillon R; Young LJ; Cardiff RD; Newman RA; Yang P; Thaler HT; Muller WJ; Hudis C; Brown AM; Hla T; Subbaramaiah K; Dannenberg AJ
    Cancer Res; 2005 Nov; 65(21):10113-9. PubMed ID: 16267038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice.
    Masuelli L; Benvenuto M; Fantini M; Marzocchella L; Sacchetti P; Di Stefano E; Tresoldi I; Izzi V; Bernardini R; Palumbo C; Mattei M; Lista F; Galvano F; Modesti A; Bei R
    J Biol Regul Homeost Agents; 2013; 27(1):105-19. PubMed ID: 23489691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic tetrathiomolybdate protects against Her2/neu-induced breast carcinoma by hypoplastic remodeling of the mammary gland.
    Pan Q; Rosenthal DT; Bao L; Kleer CG; Merajver SD
    Clin Cancer Res; 2009 Dec; 15(23):7441-6. PubMed ID: 19934283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.
    Krane IM; Leder P
    Oncogene; 1996 Apr; 12(8):1781-8. PubMed ID: 8622899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo effect of alpha-bisabolol, a nontoxic sesquiterpene alcohol, on the induction of spontaneous mammary tumors in HER-2/neu transgenic mice.
    Costarelli L; Malavolta M; Giacconi R; Cipriano C; Gasparini N; Tesei S; Pierpaoli S; Orlando F; Suzuki H; Perbellini L; Piacenza F; Emanuelli M; Mocchegiani E
    Oncol Res; 2010; 18(9):409-18. PubMed ID: 20524399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development.
    Ursini-Siegel J; Rajput AB; Lu H; Sanguin-Gendreau V; Zuo D; Papavasiliou V; Lavoie C; Turpin J; Cianflone K; Huntsman DG; Muller WJ
    Mol Cell Biol; 2007 Sep; 27(18):6361-71. PubMed ID: 17636013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M.
    Koyama H; Hibi T; Isogai Z; Yoneda M; Fujimori M; Amano J; Kawakubo M; Kannagi R; Kimata K; Taniguchi S; Itano N
    Am J Pathol; 2007 Mar; 170(3):1086-99. PubMed ID: 17322391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproductive history determines Erbb2 locus amplification, WNT signalling and tumour phenotype in a murine breast cancer model.
    Ordonez LD; Melchor L; Greenow KR; Kendrick H; Tornillo G; Bradford J; Giles P; Smalley MJ
    Dis Model Mech; 2021 May; 14(5):. PubMed ID: 34003256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenge with mammary tumor cells expressing MHC class II and CD80 prevents the development of spontaneously arising tumors in MMTV-neu transgenic mice.
    Jabrane-Ferrat N; Campbell MJ; Esserman LJ; Peterlin BM
    Cancer Gene Ther; 2006 Nov; 13(11):1002-10. PubMed ID: 16841083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of mouse mammary tumour virus (MMTV)/neu transgenic mice to identify genes collaborating with the c-erbB-2 oncogene in mammary tumour development.
    Jolicoeur P; Bouchard L; Guimond A; Ste-Marie M; Hanna Z; Dievart A
    Biochem Soc Symp; 1998; 63():159-65. PubMed ID: 9513720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of SSH&H on the lifespan and spontaneous cancer development in transgenic mice with HER-2/neu mutation].
    Tyndyk ML; Popovich IG; Anikin IV; Egormin PA; Iurova MN; Zabezhinskiĭ MA; Anisimov VN
    Vopr Onkol; 2012; 58(2):243-7. PubMed ID: 22774532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophages regulate the angiogenic switch in a mouse model of breast cancer.
    Lin EY; Li JF; Gnatovskiy L; Deng Y; Zhu L; Grzesik DA; Qian H; Xue XN; Pollard JW
    Cancer Res; 2006 Dec; 66(23):11238-46. PubMed ID: 17114237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A direct test of potential roles for beta3 and beta5 integrins in growth and metastasis of murine mammary carcinomas.
    Taverna D; Crowley D; Connolly M; Bronson RT; Hynes RO
    Cancer Res; 2005 Nov; 65(22):10324-9. PubMed ID: 16288021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.
    Zhou H; Chen WD; Qin X; Lee K; Liu L; Markowitz SD; Gerson SL
    Oncogene; 2001 Sep; 20(42):6009-17. PubMed ID: 11593408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4.
    Morini M; Astigiano S; Mora M; Ricotta C; Ferrari N; Mantero S; Levi G; Rossini M; Barbieri O
    Oncogene; 2000 Dec; 19(52):6007-14. PubMed ID: 11146552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.